Read More

Will March Inflation Data Break Tech Rally’s Back? Why Wall Street’s ‘Dean Of Valuation’ And Gene Munster Are Worried, But Paul Krugman And Other Economists Are Not

Economists generally predict a slight slowdown in the month-over-month inflation rate, with consumer prices and the core reading potentially rising by 0.3% in March compared to 0.4% in February.

TIP

Read More

3 Energy Stocks Stand Among S&P 500’s Top 10 Performers In 2024 As Oil Prices Reach $90

Sharp increase in oil prices has led to outperformance of energy stocks, with WTI rising 20% this year. EIA forecasts $90/bbl in Q2 2024 and $3.60/gal in retail gasoline prices by 2024. 3 energy firms in top 10 S&P 500 performers YTD and many more set to report earnings in April 2024.

CCJ

Read More

Enliven Therapeutics Well-Positioned, With Conservative Trading Levels-Analyst Says

Mizuho Securities initiates coverage on Enliven Therapeutics. Expectations high for late 2024 Phase 1 results. Enliven poised to revolutionize CML treatment, addressing current TKI limitations. Mizuho bullish with Buy rating, $34 price target. ELVN's trading value suggests conservative estimation compared to CML market potential.

ELVN

Read More

Goldman Sachs Is Incrementally More Positive On Molson Coors & Constellation Brands: Here’s Why

Goldman Sachs analyst Bonnie Herzog is incrementally more positive on Molson Coors Beverage & Constellation Brands but incrementally negative on Boston Beer Company based on feedback from the beer distributor contacts in the recent Beverage Bytes survey.

SAM